Your Guide to Better Health

Ipamorelin is the most selective growth hormone secretagogue available. This ipamorelin standalone guide covers its mechanism, fat loss and sleep benefits, clinical dosage protocols, side effect profile, and how it compares to GHRP-2 and GHRP-6.

The semaglutide thyroid cancer risk warning appears on every GLP-1 prescription — but is it based on human evidence? This article unpacks the FDA black box warning, explains why rodent data differs from human outcomes, and reviews the latest clinical studies so you can make an informed decision.

Learn which peptide therapy biomarkers actually measure success — from IGF-1 and HOMA-IR to testosterone and liver enzymes. The scale won't show you this.

Peptide therapy drug interactions are real and specific. This clinical reference covers GLP-1 agonists, growth hormone secretagogues, and tissue repair peptides — organized by drug class, so you know what to monitor and what to discuss with your clinician before starting any protocol.

How much does peptide therapy cost in 2026? This complete price guide breaks down real monthly costs for GLP-1s, growth hormone peptides, BPC-157, and tissue repair protocols — plus what insurance covers, how HSA/FSA funds apply, and where to get a transparent, insurance-reviewed plan.

AI peptide drug discovery is accelerating drug development through machine learning and AlphaFold. This article explains how AI designs smarter metabolic peptides and what it means for patients.

Peptides for PMOS treatment in 2026 include three distinct options targeting different biological drivers: GLP-1 RAs for insulin resistance, kisspeptin for ovulation restoration, and BPC-157 for inflammation. This deep dive covers what the current evidence actually shows — and what it doesn't.

Peptides perimenopause women hormonal health — this deep dive explains the metabolic cascade behind perimenopause and how targeted peptides (GLP-1, sermorelin, ipamorelin, BPC-157) are being used to address insulin resistance, visceral fat, and muscle loss in women 40–55.

The thymosin alpha-1 immune peptide has 30+ clinical trials and approval in 35+ countries — yet was restricted from U.S. compounding in 2023. That's changing. This guide covers the T-cell science, autoimmune applications, chronic infection evidence, and the 2026 regulatory shift bringing it back.

GLP-1 menopause weight loss is real — but postmenopausal biology changes everything. This article explains why visceral fat after 45 resists standard treatment, how semaglutide and peptide therapy interact with declining estrogen, and what a targeted protocol actually looks like.

Kisspeptin-10 women fertility ovulation: discover how this hypothalamic peptide controls the LH pulse behind ovulation, what clinical trials in IVF and PMOS show, and why it may be key to unexplained infertility. Research-driven, clinician-reviewed.

Semaglutide patent expiry biosimilar competition is arriving — but not equally everywhere. This explainer breaks down the US vs. global timeline, what the FDA's tentative generic approval means, why compounded semaglutide is no longer legal, and what cost-conscious GLP-1 users should do right now.

The RFK peptide policy 2026 shift is real. HHS Secretary Kennedy has directed the FDA to review 14 restricted peptides for compounding access — here's what the policy change means, what's actually legal now, and how to get compliant metabolic care.

A Meto peptide telehealth comparison showing how insurance-first, physician-led care differs from cash-pay platforms like AgelessRx and Hone Health — covering supervision models, out-of-pocket costs, outcome tracking, and which patients benefit most from each approach.

Category 1 category 2 peptides explained: a plain-English guide to what FDA bulk drug substance categories actually mean — which peptides are available, which aren't, and what the 2026 reclassification means for your access to clinician-supervised peptide therapy.

This peptide therapy glossary covers 60 essential terms — from GH secretagogue meaning to peptide half-life explained — across science, delivery, hormones, regulation, and monitoring. The definitive reference for anyone exploring peptide therapy through Meto's clinician-led platform.

Peptides testosterone male hormonal health: discover how growth hormone peptides like CJC-1295 and ipamorelin work alongside testosterone to restore energy, body composition, and metabolic function.

Kisspeptin male hormone optimization is one of the most evidence-backed frontiers in men's hormonal health. This deep dive covers how kisspeptin stimulates LH and testosterone, what peer-reviewed research confirms, and who is most likely to benefit from this peptide-based approach.